Linked Life Data

11446046

Source:http://linkedlifedata.com/resource/pubmed/id/11446046

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2001-7-11
pubmed:abstractText
Lung cancer is the most common cause of cancer death in developed countries. Because of the lack of efficient diagnostic tools for early detection and of efficient treatment for advanced disease, the prognosis of lung cancer is generally poor, with 10-15% surviving 5 years after diagnosis. Still, the majority of patients present with advanced disease. Stage IV disease is beyond cure and stage III disease is rarely curable with current therapies. Over the course of the last decade, rapid advances in molecular biology, pathology, bronchoscopy and radiology have provided a rational basis for earlier diagnosis and improved outcome.
pubmed:language
nor
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0029-2001
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1600-4
pubmed:dateRevised
2008-7-16
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
[Lung cancer screening--what now?].
pubmed:affiliation
Kreftavdelingen, Regionsykehuset i Tromsø 9038 Tromsø. roy.bremnes@UCHSC.edu
pubmed:publicationType
Journal Article, English Abstract, Review